Zerbib M - Search Results

1

p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors.

Pages F, Flam TA, Vieillefond A, Molinie V, Abeille X, Lazar V, Bressac-de Paillerets B, Mosseri V, Zerbib M, Fridman WH, Debré B, Thiounn N. Pages F, et al. Among authors: zerbib m. J Urol. 1998 Mar;159(3):1079-84. J Urol. 1998. PMID: 9474235

2

Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.

Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M. Peyromaure M, et al. Among authors: zerbib m. J Urol. 2003 Jun;169(6):2110-2. doi: 10.1097/01.ju.0000066840.42991.4a. J Urol. 2003. PMID: 12771729

3

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

Peyromaure M, Slama J, Beuzeboc P, Ponvert D, Debré B, Zerbib M. Peyromaure M, et al. Among authors: zerbib m. Urology. 2004 Jan;63(1):73-7. doi: 10.1016/j.urology.2003.09.018. Urology. 2004. PMID: 14751352 Review.

4

Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.

Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debré B, Amsellem-Ouazana D. Pignot G, et al. Among authors: zerbib m. Urology. 2007 Feb;69(2):230-5. doi: 10.1016/j.urology.2006.09.052. Epub 2007 Jan 31. Urology. 2007. PMID: 17275070

5

Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.

Thiounn N, Saporta F, Flam TA, Pages F, Zerbib M, Vieillefond A, Martin E, Debré B, Chevillard S. Thiounn N, et al. Among authors: zerbib m. Urology. 1997 Aug;50(2):245-50. doi: 10.1016/S0090-4295(97)00272-0. Urology. 1997. PMID: 9255296

6

High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer.

Dhote R, Beuzeboc P, Thiounn N, Flam T, Zerbib M, Christoforov B, Debré B. Dhote R, et al. Among authors: zerbib m. Eur Urol. 1998;33(4):392-5. doi: 10.1159/000019622. Eur Urol. 1998. PMID: 9612683

7

Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases.

De Pinieux G, Flam T, Zerbib M, Taupin P, Bellahcène A, Waltregny D, Vieillefond A, Poupon MF. De Pinieux G, et al. Among authors: zerbib m. J Urol. 2001 Nov;166(5):1924-30. doi: 10.1097/00005392-200111000-00085. J Urol. 2001. PMID: 11586262

8

Delayed nonurothelial metastatic lesions to the penis: a report of two cases.

Adjiman S, Flam TA, Zerbib M, Debré B, Steg A. Adjiman S, et al. Among authors: zerbib m. Eur Urol. 1989;16(5):391-2. doi: 10.1159/000471624. Eur Urol. 1989. PMID: 2776811

9

Knotting of a double pigtail stent within the ureter: an initial report.

Flam TA, Thiounn N, Gerbaud PF, Zerbib M, Debré B. Flam TA, et al. Among authors: zerbib m. J Urol. 1995 Nov;154(5):1858-9. J Urol. 1995. PMID: 7563364 No abstract available.

10

Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-alpha in the treatment of metastatic renal cell carcinoma.

Thiounn N, Mathiot C, Dorval T, Flam TA, Tartour E, Mosseri V, Zerbib M, Fridman WH, Debre B. Thiounn N, et al. Among authors: zerbib m. Br J Urol. 1995 May;75(5):586-9. doi: 10.1111/j.1464-410x.1995.tb07412.x. Br J Urol. 1995. PMID: 7613793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters